 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Creative Medical Technology Holdings Provides Corporate Update Creative Medical Technology Holdings Provides Corporate Update PR Newswire PHOENIX, Nov. 15, 2023 Continuing to Advance Regenerative...

Creative Medical Technology Holdings Provides Corporate Update

Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine using AlloStem ('CELZ-201-DDT') Novel Cell Therapy to Treat Chronic Lower...

Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine using AlloStem ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain

Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine using AlloStem (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain Creative...

Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine using AlloStem (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain

PHOENIX, AZ / ACCESSWIRE / August 24, 2023 / Biotechnology company Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) seems to be witnessing success in the allogeneic cell therapy market. In Q4...

What Is Allogeneic Cell Therapy, And Whats Driving This Markets 25%+ Annual Global Growth?

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Creative Medical Technology Holdings (CELZ Research Report), Bo... Analysts have been eager to weigh in on the Healthcare sector with new ratings on Creative Medical Technology Holdings (CELZ Research Report), Boston ...

Analysts Offer Insights on Healthcare Companies: Creative Medical Technology Holdings (CELZ), Boston Scientific (BSX) and RenovoRx (RNXT)

PHOENIX, AZ / ACCESSWIRE / July 14, 2023 / Immunotherapy, in general, is an exciting and growing sector in the pharmaceutical industry. It involves manipulating the human body's immune system to treat various diseases. While historically this type of manipulation has been associated with cancer...

The Immunotherapy Market is Expected to Surpass $351.56 Billion by 2030 - Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) is Contributing to this Growth

PHOENIX, AZ / ACCESSWIRE / July 13, 2023 / Creative Medical Technology Holdings, Inc. ('Creative Medical Technology') (NASDAQ:CELZ) recently released an update on their drug pipeline and financial standing going into Q3 2023. The biotechnology company is known for its regenerative...

Creative Medical Technology Reports Advancements In Regenerative Medicine And Improvements In Financial Position In Corporate Update

Creative Medical Technology Holdings, Inc. ("Creative Medical Technology") (NASDAQ: CELZ) recently released an update on their scientific pipeline and financial standing going into Q3 2023.
read more...

Creative Medical Technology Holdings Inc. (NASDAQ: CELZ) Reports Advancements In Its Immunotherapy Programs And Confidence In Its Financial Position In Corporate Update

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ Free Report) was the target of a large decline in short interest during the month of June. As of June 15th, there was short interest totalling 32,100 shares, a decline of 90.9% from the May 31st total of 351,300 shares. Approximately 2.3% of ...

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Short Interest Update

Creative Medical Technology Holdings Provides Corporate Update Creative Medical Technology Holdings Provides Corporate Update PR Newswire PHOENIX, June 12, 2023 Continued Advancements in Developing Regenerative Therapeutics While Maintaining Strong Financial Position PHOENIX, June 12, 2023...

Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company which focuses on immunology, urology, neurology and orthopedics using adult stem cell treatments and interrelated regenerative technologies for the treatment of multiple indications. Its products include CaverStem, FemCelz, StemSpine, and ImmCelz. The company was founded on December 3, 1998 and is headquartered in Phoenix, AZ.

Market Cap	$6.22M
Volume (M)	5,360.00
52-Wk High	$14.20
52-Wk Low	$3.46

CELZ Creative Medical Technology Holdings Inc

About

Feed

News

Fundamentals